Ionis Pharmaceuticals reported $4.52B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Arrowhead Research USD 11.5B 2.72B Jun/2026
Astellas Pharma JPY 4.78T 582.95B Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Celltrion KRW 1.81T 620B Jun/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Divis Laboratories Ltd INR 3.07T 598.82B Nov/2026
Exelixis USD 19.82B 5.34B Nov/2026
Halozyme Therapeutics USD 15.62B 3.09B Nov/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Moderna USD 99.14B 22.26B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Neurocrine Biosciences USD 16.38B 1.96B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
OPKO Health USD 3.71B 332.87M Nov/2026
Organigram Holdings CAD 128.48M 74.94M Nov/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pfizer USD 165.12B 1.71B Nov/2026
Pharma Mar EUR 1.17B 85.18M Nov/2026
Qiagen NV USD 10.01B 2.04B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Sartorius EUR 17.42B 1.8B Sep/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026
Zz Pientze Pharmaceu CNY 76.62B 5.43B Nov/2026